Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology
NCT02123797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 781
Last updated 2020-07-02
Summary
Lung cancer kills 160,000 patients annually; this represents 28% of all US cancer deaths. The overall year survival rate has only improved from 12% to 17% in 33 years. This failure reflects the innate lethality of lung cancer, but also reflects defects in patient care delivery. Care for the lung cancer patient starts with an abnormal radiologic scan, proceeds through a diagnostic biopsy, tests to determine the extent of spread of the disease (stage), selection of appropriate treatment, and finally ends with patient outcomes. At each step are multiple options and independent specialists, each one engaged by a process of sequential referrals in the serial care model. This process is often not user-friendly, is riddled with inefficiency, delays, and outcome variances.
The coordinated multidisciplinary model, in which patients and their doctors collaborate to provide evidence-based care, is believed by experts to be superior, but has few examples of successful implementation. The implementation gap exists because of the paucity of good quality data, and lack of implementation know-how.
Embedded in the highest US lung cancer mortality zone, the greater Memphis area has a racially, culturally, economically and geographically diverse population. The investigators research group has shown how poor quality care impairs patient survival in this region and in the greater US. The investigators have linked patient survival to compliance with multidisciplinary care plans. In this project, the investigators propose to rigorously test the impact of the multidisciplinary care model on patient outcomes in a community-based, private practice environment, similar to where 70% of lung cancer care is delivered in the US.
The objective of this study is to provide high-level evidence of the impact of multidisciplinary care on lung cancer patient outcomes. Multidisciplinary care is defined as a model of care in which patients, their care-givers and key specialists concurrently and directly evaluate the same patients in the presence of the patients and their informal caregivers, in order to develop evidence-based consensus care plans
Conditions
Sponsors & Collaborators
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
Baptist Memorial Health Care Corporation
lead OTHER
Principal Investigators
-
Raymond Osarogiagbon · Baptist Memorial Health Care Corporation
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-09
- Primary Completion
- 2017-10-31
- Completion
- 2020-02-29
Countries
- United States
Study Locations
More Related Trials
-
Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas
NCT02891733 ·Status: WITHDRAWN
-
Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes
NCT07215026 ·Status: COMPLETED
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT05049837 ·Status: RECRUITING
-
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
NCT02190864 ·Status: UNKNOWN
-
Tumor Mutational Burden in Lung Cancer Patients
NCT04289259 ·Status: TERMINATED
-
Quality of Life as a Predictor of OS and PFS in Patients With Lung Cancer
NCT06900283 ·Status: ACTIVE_NOT_RECRUITING
-
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
NCT02121925 ·Status: TERMINATED
-
K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications
NCT01023828 ·Status: COMPLETED
-
The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung Cancer
NCT06000358 ·Status: RECRUITING ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase
NCT06441773 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate Guideline Adoption Through Quality Improvement Project (QIP) in Pulmonary and Critical Care Medicine (PCCM) Department
NCT06484972 ·Status: NOT_YET_RECRUITING
-
Non-small Cell Lung Cancer and Quality of Life
NCT00818402 ·Status: COMPLETED
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members
NCT03966807 ·Status: TERMINATED
-
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
NCT06738680 ·Status: NOT_YET_RECRUITING
-
Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"
NCT05157503 ·Status: UNKNOWN
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Global, Regional, and National Burdens and Trends of Tracheal, Bronchial, and Lung Cancer in Individuals Aged 70 Years and Older from 1990 to 2021
NCT06694194 ·Status: COMPLETED
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
Virtual Intervention for Lung Cancer
NCT01684696 ·Status: WITHDRAWN ·Phase: NA
-
A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
NCT07121387 ·Status: COMPLETED
-
Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)
NCT05605236 ·Status: COMPLETED